Do GLP-1 medications lower breast cancer risk?

In a 2026 Penn Medicine study of over 110,000 women, those taking a GLP-1 were about 30% less likely to be diagnosed with breast cancer. The study was observational, so it shows a strong association rather than proof of cause, and a clinical trial is being planned.

Is the lower breast cancer risk just because of the weight loss?

Not entirely, it appears. When researchers matched women by BMI and diabetes status, GLP-1 users still had roughly 30% lower odds, suggesting effects beyond weight loss, likely including reduced inflammation.

Which medications were involved in the study?

GLP-1 receptor agonists, the drug class that includes semaglutide and tirzepatide. The study did not break results down by specific medication or length of use.

Should I stop breast cancer screening if I'm on a GLP-1?

No. This research is promising but early, and it is not a substitute for mammograms or MRI. Keep up with the screening your doctor recommends.

Where can I start medically supervised semaglutide or tirzepatide near me?

Pacific Northwest Medical Group offers physician-supervised GLP-1 weight loss programs at clinics in Puyallup and Federal Way, Washington, with free consultations.

What is GLP-1 weight loss?

GLP-1 medications such as semaglutide and Tirzepatide help control appetite, reduce cravings, and support healthy weight loss when combined with medical supervision and lifestyle changes.

How does the program work?

Your program starts with a free consultation, body scan, and personalized treatment plan including GLP-1 medication, nutrition guidance, and regular follow-ups.

How long does it take to see results?

Most patients notice changes within 2–4 weeks, with significant results typically seen in 3–6 months.

What's included in the program?

The program includes consultations, GLP-1 medication, body scans, nutrition counseling, and ongoing clinical support.

Do I need to visit the clinic in person?

An initial consultation is required. After that, patients may visit for medication or choose home administration when appropriate.

Is the first week of medication free?

Yes. Your first week of GLP-1 medication is provided at no cost during your consultation.

What medications do you use?

We prescribe compounded semaglutide and compounded Tirzepatide based on your medical needs.

Are there side effects?

Possible side effects include mild nausea, upset stomach, and reduced appetite. Our team monitors your progress and adjusts treatment if needed.

Do you accept insurance?

Our GLP-1 weight loss program is currently self-pay. Financing options are available.

Are you LegitScript Certified?

Yes. Pacific Northwest Medical Group is LegitScript certified, demonstrating compliance with recognized healthcare standards.

Could Your GLP-1 Be Lowering Your Breast Cancer Risk Too?

Jun 11
2 min read

Updated: Jul 21

Hey everyone –

Short version: a big new study out of Penn Medicine looked at more than 110,000 women and found the ones taking a GLP-1 were about 30% less likely to develop breast cancer. And the part that got my attention — the protection held up even after they matched women by weight and diabetes status. So this looks like more than "just" the weight loss.

(original research article at the bottom of my summary, as always)

This one really lit up my engineering brain. We already talk about what these meds do for weight, blood sugar, heart, knees, even aging. But cancer? That's big — and breast cancer hits close to home for a lot of the women in our clinic.

Here's what they actually found. Researchers at Penn's Abramson Cancer Center pulled records on 111,646 women ages 45 to 80. About 15,000 were on a GLP-1. In the full group: 35% lower odds of a new breast cancer diagnosis. Then they did the careful "apples-to-apples" match — age, race, breast density, BMI, diabetes status — and it was still about 30% lower.

That matched number is the interesting part. We've known forever that extra weight raises breast cancer risk, so you'd expect a weight-loss med to help by trimming pounds. Obvious. But two women at the same weight, one on a GLP-1 and one not — the GLP-1 user still came out meaningfully lower. That suggests something beyond the scale is at work. Leading theory: these meds calm the chronic low-grade inflammation that drives a lot of disease. Same theme we keep seeing — they do more under the hood than move the scale.

I'll be straight with you, like always: this was observational. Strong link, not proof of cause. Nobody's calling it a cancer cure, and nobody should skip their mammograms — screening still matters, full stop.

But a possible 30% lower risk on top of everything else? That's a big deal for the women we treat. Worth watching.

-Daryl

Book a FREE consult now <- Click There!

www.pnwmedicalgroup.com

Puyallup: 253-340-2270

Federal Way: 253-363-8877